Document is current

Article History

Received: 19 March 2020

Revised: 3 June 2020

Accepted: 20 July 2020

First Online: 7 August 2020

Compliance with ethical standards

:

: The scientific guarantor of this publication is David Bonekamp.

: Patrick Schelb has nothing to declare.Xianfeng Wang has nothing to declare.Jan Philipp Radtke declares payment for consultant work from Saegeling Medizintechnik and Siemens Heathineers and for development of educational presentations from Saegeling Medizintechnik.Manuel Wiesenfarth has nothing to declare.Philipp Kickingereder has nothing to declare.Albrecht Stenzinger declares: Advisory Board/Speaker’s Bureau: Astra Zeneca, Bayer, BMS, Eli Lilly, Illumina, Janssen, MSD, Novartis, Pfizer, Roche, Seattle Genetics, Thermo Fisher. Grants: Bayer, BMS, Chugai.Markus Hohenfellner has nothing to declare.Heinz-Peter Schlemmer declares receiving consulting fees or honoraria: Siemens, Curagita, Profound, and Bayer; receiving travel support: Siemens, Curagita, Profound, and Bayer; being a board member: Curagita; consultancy: Curagita and Bayer; grants/grants pending: BMBF, Deutsche Krebshilfe, Dietmar-Hopp-Stiftung, and Roland-Ernst-Stiftung; and payment for lectures: Siemens, Curagita, Profound, and Bayer.Klaus Maier-Hein has nothing to declare.David Bonekamp declares receiving consulting fees or honoraria: Profound Medical Inc. and Bayer Vital, and payments for lectures: Profound Medical Inc. and Bayer Vital.

: Manuel Wiesenfarth is the lead statistician and co-author of this paper.

: Written informed consent was waived by the Ethics Commission.

: Ethical approval was obtained.

: • retrospective• diagnostic study• Single-center study